Vise Technologies, Inc. Haemonetics Corp Transaction History
Vise Technologies, Inc.
- $771 Million
- Q3 2024
A detailed history of Vise Technologies, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Vise Technologies, Inc. holds 2,600 shares of HAE stock, worth $162,136. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,600
Previous 3,573
27.23%
Holding current value
$162,136
Previous $295,000
29.49%
% of portfolio
0.03%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding HAE
# of Institutions
351Shares Held
56MCall Options Held
544KPut Options Held
438K-
Black Rock Inc. New York, NY5.96MShares$372 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$323 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$276 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$264 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA3.94MShares$246 Million0.06% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.2B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...